Quantcast

Latest infection Stories

2014-10-09 12:28:58

Results for groundbreaking multi-center study of lead drug candidate RBX2660 (microbiota suspension) presented at IDWeek 2014 PHILADELPHIA, Oct. 9, 2014 /PRNewswire/ -- Rebiotix Inc. announced today that results of the Phase 2 PUNCH(TM) CD Study found that the overall efficacy of RBX2660 in the treatment of recurrent Clostridium difficile infection was 87.1%. The study also found that administration of RBX2660 was well-tolerated and demonstrated satisfactory safety in the 60-day...

2014-10-09 08:27:05

SARASOTA, Fla., Oct. 9, 2014 /PRNewswire-USNewswire/ -- RPS Diagnostics, Inc. (RPS®) today announced CE mark of its FebriDx(TM) test, clearing the way for sales in the European Union and all countries recognizing the CE mark. http://photos.prnewswire.com/prnvar/20141008/151092 FebriDx is a rapid, disposable, in-office test that helps identify and differentiate a clinically significant immune response to viral and/or bacterial acute febrile respiratory infection at the...

2014-10-08 08:26:30

PHILADELPHIA, Oct. 8, 2014 /PRNewswire/ -- A major North Carolina medical center announces that studies have conclusively demonstrated that the PhotoxAir(TM) purification system significantly reduced airborne bacteria in clinical trials conducted in an emergency department setting. The data was presented at ID Week; the annual meeting of the Infectious Diseases Society of America, the Society Healthcare Epidemiology of America, the HIV Medicine Association and the Pediatric...

2014-10-06 08:28:03

Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct. 6, 2014 /PRNewswire/ -- Savara Pharmaceuticals announced today that it closed a $10 million bridge financing round to support the development of AeroVanc, the first inhaled antibiotic being developed to address the growing number of methicillin-resistant Staphylococcus aureus (MRSA) lung infections in people with cystic fibrosis (CF). Previous investors participated in the financing, and new investors include...

2014-10-02 12:30:51

DUBLIN, Oct. 2, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Hospital Infection Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Hospital infection is also referred to as healthcare-associated infection (HCAI) or nosocomial infection or hospital-acquired infection (HAI). HAI are those infections that develop in...

2014-10-02 08:29:52

First rapid test to distinguish between pathogenic and non-pathogenic species WALTHAM, Mass., Oct. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today that the new E. HISTOLYTICA QUIK CHEK(TM) test, which identifies the Entamoeba histolytica parasite, has received CE Mark for sale in international markets outside of the United States. The test is developed and manufactured by TECHLAB(®) Inc. Entamoeba histolytica is an intestinal...

2014-10-01 12:31:15

Rebiotix lead drug candidate RBX2660 (microbiota suspension) assessed in PUNCH CD study ROSEVILLE, Minn., Oct. 1, 2014 /PRNewswire/ -- Rebiotix Inc. announced this morning that results of PUNCH CD, a Phase 2 study of the company's lead product candidate, RBX2660 (microbiota suspension), will be presented in three posters at the American College of Gastroenterology (ACG) Annual Scientific Meeting in Philadelphia from October 17-22. The following poster will be presented on Monday, October 20,...

2014-09-30 23:22:34

LRA receives record number of grant applications to advance Lyme disease research. Funds seven promising studies to find a reliable diagnostic test and effective treatment options for Lyme and other tick-borne diseases. Stamford, CT (PRWEB) September 30, 2014 Lyme Research Alliance (LRA), the nation’s largest private non-profit funder of Lyme disease research at universities, today announced the awarding of seven grants worth $587,000 to researchers focused on the identification,...

2014-09-30 23:15:44

New software will complement TMC's commitment of providing superior service and quality of care for its patients Toronto, ON (PRWEB) September 30, 2014 RL Solutions, creators of innovative and easy to use healthcare quality and safety software, announced today that Tucson Medical Center (TMC) has selected RL Solutions to provide a suite of quality and safety software, including risk management, patient feedback, infection surveillance, root cause analysis and claims management. TMC is...

2014-09-29 08:30:22

DUBLIN, Sept. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Infectious Disease Treatment Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to...


Latest infection Reference Libraries

0_ce8c5b23d8785d6957f1484978ad758f
2011-04-28 18:03:11

Yersinia enterocolitica is a species of gram-negative coccobacillus-shaped bacterium, belonging to the family Enterobacteriaceae. Infection from Yersinia enterocolitica causes the zoonotic disease yersiniosis. Most infected animals recover from the disease and become asymptomatic carriers. Acute infections lead to mild self-limiting entero-colitis or terminal ileitis in humans. Symptoms include watery or bloody diarrhea and fever. After oral uptake it replicates in the terminal ileum and...

69_25ca82414f9e3d4dc58f4e0304b9dfb5
2011-04-28 17:02:45

Labor Induction is a process of giving an artificial start to birth with medical intervention or other methods. When an induction is not performed for emergency or other medical reasons, the method is considered an elective process. The decision to induce labor has increased in recent years due to its convenience or because it easily accommodates busy schedules. The American College of Obstetricians and Gynecologists, however, say that labor should only be induced when it is more risky...

0_cef863082995e6cb66fa4a692bf165a7
2011-04-28 16:37:36

Vibrio vulnificus is a species of Gram-negative, motile, curved, rod-shaped bacteria of the Vibrio Genus. Hollis et al. first reported it in 1976. It was given the name Beneckea vulnifica by Reichelt et al. in 1976 and in 1979 Vibrio vulnificus by Farmer. V. vulnificus is related to V. cholerae and is present in marine environments such as estuaries, brackish ponds, or coastal areas. It causes an infection often incurred after eating seafood, especially raw or undercooked oysters. It can...

0_565be8ac4669df235cfa9eb09fa14a3d
2011-04-26 20:59:00

Staphylococcus epidermidis is one of thirty-three known species belonging to the genus Staphylococcus. It is part of our skin flora and can also be found in the mucous membranes and in animals. It is the most common species found in laboratory test due to contamination. It is not usually pathogenic; however, patients with a compromised immune system often risk infection. Infections can be both nosocomial and community acquired and are more of a threat to hospital patients. Hospitals carry...

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (18 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.